Where does PASW stock trade?

Ping An Biomedical Co. Ltd. (PASW) is listed on NASDAQ.

What sector and industry is PASW in?

Ping An Biomedical Co. Ltd. operates in the Consumer Discretionary sector, Apparel industry.

When did Ping An Biomedical Co. Ltd. go public?

Ping An Biomedical Co. Ltd. (PASW) completed its IPO in 1999.

What companies are similar to PASW?

Notable peers in the same industry include TPR (Tapestry Inc.), AS (Amer Sports Inc.), LULU (lululemon athletica inc.), GIL (Gildan Activewear Inc.), LEVI (Levi Strauss & Co). Compare PASW side-by-side with any of them on Quantisnow.

How can I track PASW on Quantisnow?

Quantisnow aggregates Ping An Biomedical Co. Ltd.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PASW to receive live email and push alerts on every new disclosure.

PASW

NASDAQ

Ping An Biomedical Co. Ltd.

SectorConsumer DiscretionaryIndustryApparelIPO1999

$0.17-0.01 (-4.32%)

News18/Ratings0

Price$0.17+0.01 (+8.17%)

2026-03-042026-06-05

News · 26 weeks16+100%

2025-12-142026-06-07

Mix890d

Insider5(63%)
SEC Filings2(25%)
Other1(13%)

Latest news

18 items

11dSEC
SEC Form 6-K filed by Ping An Biomedical Co. Ltd.
6-K - Ping An Biomedical Co., Ltd. (0001897532) (Filer)
61dINSIDER
SEC Form 3 filed by new insider Liu Pijun (Pjl)
3 - Ping An Biomedical Co., Ltd. (0001897532) (Issuer)
68dINSIDER
SEC Form 3 filed by new insider Liu Xianzhi (Xzl)
3 - Ping An Biomedical Co., Ltd. (0001897532) (Issuer)
68dINSIDER
SEC Form 3 filed by new insider Yang Hongli (Hly)
3 - Ping An Biomedical Co., Ltd. (0001897532) (Issuer)
80dSEC
SEC Form 6-K filed by Ping An Biomedical Co. Ltd.
6-K - Ping An Biomedical Co., Ltd. (0001897532) (Filer)
80dPR
All Resolutions Passed at Ping An Biomedical AGM, Clearing Path for Restructured Share Capital
HONG KONG, March 19, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd (NASDAQ:PASW) (hereinafter referred to as "Ping An Bio") announced that shareholders have approved all five resolutions at the company's 2026 Annual General Meeting, providing full authorization for an overhaul of its share capital structure, the introduction of high‑vote Class B shares, a targeted share exchange with a major shareholder, and a large‑scale share consolidation. Authorised Share Capital Changes Shareholders resolved by an ordinary resolution that, the Company authorised share capital of the Company be amended in the manner and sequence set out below with immediate effect (collectively, the Authorise
81dINSIDER
SEC Form 3 filed by Ping An Biomedical Co. Ltd.
3 - Ping An Biomedical Co., Ltd. (0001897532) (Issuer)
81dINSIDER
SEC Form 3 filed by Ping An Biomedical Co. Ltd.
3 - Ping An Biomedical Co., Ltd. (0001897532) (Issuer)
90dSEC
SEC Form 6-K filed by Ping An Biomedical Co. Ltd.
6-K - Ping An Biomedical Co., Ltd. (0001897532) (Filer)
101dSEC
SEC Form EFFECT filed by Ping An Biomedical Co. Ltd.
EFFECT - Ping An Biomedical Co., Ltd. (0001897532) (Filer)
114dSEC
SEC Form F-1 filed by Ping An Biomedical Co. Ltd.
F-1 - Ping An Biomedical Co., Ltd. (0001897532) (Filer)
115dSEC
SEC Form 6-K filed by Ping An Biomedical Co. Ltd.
6-K - Ping An Biomedical Co., Ltd. (0001897532) (Filer)
128dSEC
SEC Form 20-F filed by Ping An Biomedical Co. Ltd.
20-F - Ping An Biomedical Co., Ltd. (0001897532) (Filer)
146dSEC
SEC Form 6-K filed by Ping An Biomedical Co. Ltd.
6-K - Ping An Biomedical Co., Ltd. (0001897532) (Filer)
149dPR
Ping An Biomedical Co., Ltd Announces Strategic Investment in Future Biotechnology Group to Advance Collaborative Development of the Biopharmaceutical Industry
HONG KONG, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd (NASDAQ:PASW) (hereinafter referred to as "Ping An Bio") announced that it has entered into a non-binding memorandum (the "Investment Memorandum") with Future Biotechnology Group Co., Ltd (hereinafter referred to as "Future Biotechnology Group"). The Investment Memorandum outlines an initial investment of US$30 million to be paid in cash, as well as subsequent acquisitions with a consideration, in aggregate, of US$60 million to be settled in cash and share issuances (the "Consideration Shares"). The Consideration Shares are to be held escrow and released in accordance with performance targets over an evaluation perio
150dPR
Ping An Biomedical Co., Ltd. Receives Strategic Investment from Leading Industry Capital, Accelerating Growth in Biopharmaceutical Innovation
HONG KONG, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (NASDAQ:PASW) (hereinafter referred to as "Ping An Bio") today announced that it has entered into a series of share purchase agreements with several investors. Ping An Biomedical Co., Ltd. has entered into a series of share purchase agreements from several investors: Yao Jinbo, Chairman and CEO of 58 Group Inc.; Wang Donghui, Founder and Managing Partner of Amiba Capital Co., Ltd; and Li Daxue, Chairman and CEO of Magcloud Group Co., Ltd and former Senior Vice President of JD.com and its Lifetime Honorary Advisor. This round of investment further strengthens the company's long-term development in biopharmaceutical R
192dSEC
SEC Form 6-K filed by Ping An Biomedical Co. Ltd.
6-K - Ping An Biomedical Co., Ltd. (0001897532) (Filer)
192dPR
Ping An Biomedical Co., Ltd. Announces Receipt of Nasdaq Minimum Bid Price Deficiency Letter
Hong Kong, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (NASDAQ:PASW) (the "Company") today announced receipt of Nasdaq Minimum Bid Price Deficiency Letter. On November 24, 2025, Ping An Biomedical Co., Ltd. (the "Company") received a letter from the Listing Qualifications staff of The Nasdaq Stock Market ("Nasdaq") notifying the Company that based on the closing bid price of the Company for the period from October 10, 2025 to November 20, 2025, the Company no longer meets the continued listing requirement of Nasdaq under Nasdaq Listing Rules 5550(a)(2), to maintain a minimum bid price of $1 per share. Nasdaq has provided the Company with an 180 calendar days complianc

PASW FAQ

5 questions

Where does PASW stock trade?
Ping An Biomedical Co. Ltd. (PASW) is listed on NASDAQ.
What sector and industry is PASW in?
Ping An Biomedical Co. Ltd. operates in the Consumer Discretionary sector, Apparel industry.
When did Ping An Biomedical Co. Ltd. go public?
Ping An Biomedical Co. Ltd. (PASW) completed its IPO in 1999.
What companies are similar to PASW?
Notable peers in the same industry include TPR (Tapestry Inc.), AS (Amer Sports Inc.), LULU (lululemon athletica inc.), GIL (Gildan Activewear Inc.), LEVI (Levi Strauss & Co). Compare PASW side-by-side with any of them on Quantisnow.
How can I track PASW on Quantisnow?
Quantisnow aggregates Ping An Biomedical Co. Ltd.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PASW to receive live email and push alerts on every new disclosure.